Literature DB >> 24026241

Frequent-relapsing, steroid-dependent minimal change disease: is rituximab the answer?

Fernando C Fervenza1, Sanjeev Sethi.   

Abstract

Entities:  

Keywords:  minimal change disease; nephrotic syndrome; relapses; rituximab; steroid

Mesh：

Substances：

Year:  2013        PMID： 24026241     DOI： 10.1093/ndt/gft366

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  5 in total

1.  American Society of Nephrology quiz and questionnaire 2013: glomerulonephritis.

Authors:  Fernando C Fervenza; Mark A Perazella; Michael J Choi
Journal:  Clin J Am Soc Nephrol       Date:  2014-02-27       Impact factor: 8.237

2.  First case of low-dose umbilical cord blood therapy for pediatric acute respiratory distress syndrome induced by Pneumocystis carinii pneumonia.

Authors:  Shuang Liu; Huili Shen; Siyuan Huang; Rong Liu; Dong Qu
Journal:  Eur J Med Res       Date:  2021-08-28       Impact factor: 2.175

3.  The efficacy of rituximab in adult frequently relapsing minimal change disease.

Authors:  Catherine King; Sarah Logan; Stuart W Smith; Peter Hewins
Journal:  Clin Kidney J       Date:  2016-10-24

Review 4.  Therapeutic trials in adult FSGS: lessons learned and the road forward.

Authors:  An S De Vriese; Jack F Wetzels; Richard J Glassock; Sanjeev Sethi; Fernando C Fervenza
Journal:  Nat Rev Nephrol       Date:  2021-05-20       Impact factor: 28.314

5.  A higher frequency of CD4⁺CXCR5⁺ T follicular helper cells in adult patients with minimal change disease.

Authors:  Nan Zhang; Pingwei Zhao; Amrita Shrestha; Li Zhang; Zhihui Qu; Mingyuan Liu; Songling Zhang; Yanfang Jiang
Journal:  Biomed Res Int       Date:  2014-08-27       Impact factor: 3.411
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.